↓ Skip to main content

No influence of the polymorphisms CYP2C19 and CYP2D6 on the efficacy of cyclophosphamide, thalidomide, and bortezomib in patients with Multiple Myeloma

Overview of attention for article published in BMC Cancer, August 2010
Altmetric Badge

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
44 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
No influence of the polymorphisms CYP2C19 and CYP2D6 on the efficacy of cyclophosphamide, thalidomide, and bortezomib in patients with Multiple Myeloma
Published in
BMC Cancer, August 2010
DOI 10.1186/1471-2407-10-404
Pubmed ID
Authors

Annette J Vangsted, Karen Søeby, Tobias W Klausen, Niels Abildgaard, Niels F Andersen, Peter Gimsing, Henrik Gregersen, Ulla Vogel, Thomas Werge, Henrik B Rasmussen

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 2%
Chile 1 2%
Unknown 42 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 20%
Other 5 11%
Professor 5 11%
Student > Ph. D. Student 5 11%
Student > Bachelor 4 9%
Other 11 25%
Unknown 5 11%
Readers by discipline Count As %
Medicine and Dentistry 22 50%
Agricultural and Biological Sciences 5 11%
Biochemistry, Genetics and Molecular Biology 4 9%
Pharmacology, Toxicology and Pharmaceutical Science 2 5%
Economics, Econometrics and Finance 2 5%
Other 3 7%
Unknown 6 14%